Abstract | AIM: To investigate the effect of dioxonaphthoimidazolium analog YM155 on cell cycle progression of the clear-cell variant of renal cell carcinoma (ccRCC). MAIN METHODS: Cell cycle analysis was performed using bromodeoxyuridine ( BrdU) and PI, apoptosis initiation was monitored using Annexin V and proteins expression was determined using western immunoblotting. KEY FINDINGS: Here, we showed that YM155 activated stress-related molecules ( histone H2AX, checkpoint kinases Chk1 and Chk2, p53) that mediate DNA damage checkpoint responses. The coordinated activation of these effector molecules disrupts progression of the cell cycle at the S phase as deduced from BrdU pulsing experiments and the ensuing changes in the levels of proteins ( cyclins, CDKs, CDK inhibitors, phosphatases) that control cell cycle progression. Notably, we found increases in cyclin E and Cdc2 which regulate transition of cells from G1 to S, even as losses were observed for other CDKs and their cyclin partners. Furthermore, by inducing a loss in total pRb possibly by promoting its degradation, YM155 promoted the E2F transcription of genes that regulate entry into the S phase. After 24 h, cell cycle arrest to repair YM155-inflicted DNA damage was overtaken by p53-mediated apoptosis. YM155 induced increases in pro-apoptotic proteins (Bax and Bad), diminished anti-apoptotic proteins (Mcl-1, Bcl-xl, XIAP, survivin) and initiated cleavage of apoptotic marker proteins caspase 3 and PARP. SIGNIFICANCE: Taken together, the added insight provided on the cell cycle perturbative effects of YM155 may assist clinicians in framing rational choices for combining YM155 with other anti- cancer drugs or treatment modalities in ccRCC.
|
Authors | Mei Yi Sim, Mei Lin Go, John Shyi Peng Yuen |
Journal | Life sciences
(Life Sci)
Vol. 203
Pg. 282-290
(Jun 15 2018)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 29689274
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 Elsevier Inc. All rights reserved. |
Chemical References |
- Cell Cycle Proteins
- Imidazoles
- Naphthoquinones
- sepantronium
|
Topics |
- Apoptosis
(drug effects)
- Carcinoma, Renal Cell
(drug therapy, metabolism, pathology)
- Cell Cycle
(drug effects)
- Cell Cycle Proteins
(metabolism)
- Cell Proliferation
(drug effects)
- Humans
- Imidazoles
(pharmacology)
- Kidney Neoplasms
(drug therapy, metabolism, pathology)
- Naphthoquinones
(pharmacology)
- Tumor Cells, Cultured
|